Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.05% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
InMode
INMD
$872M
| $911K | ﹤0.01% |
25,510
-6,901
| -21% | -$240K |
|
3227
Vermilion Energy
VET
$1.74B
| $910K | ﹤0.01% |
51,396
-3,335
| -6% | -$67.7K |
|
3228
Ceco Environmental
CECO
$4.54B
| $909K | ﹤0.01% |
77,820
+31,091
| +67% | +$352K |
|
|
CCRD
3229
DELISTED
CoreCard
CCRD
| $909K | ﹤0.01% |
31,367
+1,347
| +4% | +$35.3K |
|
3230
Blue Ridge Bankshares
BRBS
$333M
| $909K | ﹤0.01% |
72,749
-17,233
| -19% | -$223K |
|
3231
Lindblad Expeditions
LIND
$2.24B
| $906K | ﹤0.01% |
117,603
+1,931
| +2% | +$16.3K |
|
3232
NuScale Power
SMR
$3.94B
| $905K | ﹤0.01% |
88,164
+308
| +0.4% | +$3.41K |
|
|
AMPS
3233
DELISTED
Altus Power
AMPS
| $902K | ﹤0.01% |
138,407
-31,661
| -19% | -$258K |
|
3234
Nuvation Bio
NUVB
$2.1B
| $901K | ﹤0.01% |
469,360
+28,837
| +7% | +$58.3K |
|
3235
Arhaus
ARHS
$1.39B
| $900K | ﹤0.01% |
+92,358
| New | +$806K |
|
3236
C4 Therapeutics
CCCC
$492M
| $900K | ﹤0.01% |
152,502
+666
| +0.4% | +$5.52K |
|
3237
WBI BullBear Yield 3000 ETF
WBIG
$32.7M
| $900K | ﹤0.01% |
37,238
-1,374
| -4% | -$34.6K |
|
3238
Phathom Pharmaceuticals
PHAT
$751M
| $897K | ﹤0.01% |
79,935
+6,415
| +9% | +$66.1K |
|
3239
Cognyte Software
CGNT
$676M
| $893K | ﹤0.01% |
287,190
-14,459
| -5% | -$42.5K |
|
3240
Adicet Bio
ACET
$77M
| $891K | ﹤0.01% |
6,231
-2,175
| -26% | -$543K |
|
3241
Oportun Financial
OPRT
$355M
| $890K | ﹤0.01% |
161,614
+50,441
| +45% | +$264K |
|
3242
State Street SPDR S&P International Small Cap ETF
GWX
$932M
| $890K | ﹤0.01% |
30,277
-321
| -1% | -$9.08K |
|
3243
Archer Aviation
ACHR
$5.16B
| $888K | ﹤0.01% |
474,939
-80,431
| -14% | -$198K |
|
3244
The ONE Group
STKS
$56.8M
| $885K | ﹤0.01% |
140,548
+30,069
| +27% | +$197K |
|
3245
Fidelity D&D Bancorp
FDBC
$322M
| $883K | ﹤0.01% |
18,735
+149
| +0.8% | +$6.81K |
|
3246
GoodRx Holdings
GDRX
$1.26B
| $880K | ﹤0.01% |
188,737
+143,145
| +314% | +$705K |
|
3247
Altimmune
ALT
$564M
| $877K | ﹤0.01% |
53,292
-19,804
| -27% | -$222K |
|
|
WE
3248
DELISTED
WeWork Inc.
WE
| $876K | ﹤0.01% |
15,306
+1,328
| +10% | +$124K |
|
3249
Heron Therapeutics
HRTX
$62.7M
| $874K | ﹤0.01% |
349,415
+1,779
| +0.5% | +$5.73K |
|
3250
Alto Ingredients
ALTO
$325M
| $873K | ﹤0.01% |
303,060
+44,110
| +17% | +$157K |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.